In addition, reduced expression or inactivation of pleckstrin homology-like domain family A member 1 (PHLDA1)—a critical negative regulator of PI3K–AKT signaling—can unleash AKT activity and promote a resistant phenotype, a mechanism functionally validated in multiple RTK-driven tumor models [285,286]. The gene discussed is AKT1; the disease is neoplasm.